We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Study: AI Could Save 5-10% in Healthcare Spending

By HospiMedica International staff writers
Posted on 30 Jan 2023
Image: Researchers expect broader adoption of AI in healthcare in the near future (Photo courtesy of Pexels)
Image: Researchers expect broader adoption of AI in healthcare in the near future (Photo courtesy of Pexels)

A new study by McKinsey & Company (New York City, NY, USA) and Harvard University (Cambridge, MA, USA) estimates that the broader adoption of AI could lead to savings in the range of 5% to 10% in healthcare spending, or between approximately USD 200-360 billion per year in the US.

Presently, the healthcare sector has low adoption of AI-based tools despite its benefits discovered by researchers. The study's estimates are based on AI uses utilizing current technologies that are achievable within the next five years, without compromising quality or access. Hospitals could see cost savings mainly through improved clinical operations, quality and safety – such as optimizing operating rooms, or identifying adverse events. Physician groups can experience similar benefits by leveraging AI for continuity of care, such as referral management.

Health insurers could experience savings from uses that improve claims management, such as automating prior authorization, along with healthcare and provider relationship management, including preventing readmissions and provider directory management. Based on AI-driven uses, private payers could save approximately 7% to 9% of their total costs within the next five years. Physician groups could save 3% to 8% of their costs. Additionally, the report estimates that hospitals could register savings between 4% to 11% in their expenses per year.

Related Links:
McKinsey & Company
Harvard University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
IV Therapy Cart
Avalo I.V Therapy Cart
New
Steam Sterilizer
AMSCO 400 Series

Channels

Critical Care

view channel
Image: Researchers have unlocked the heart’s hidden geometry that could revolutionize ECG interpretation (Photo courtesy of KCL)

Discovery of Heart’s Hidden Geometry to Revolutionize ECG Interpretation

Electrocardiograms (ECGs) are one of the most widely used tools in diagnosing heart conditions, but their accuracy can be affected by natural variations in individual heart anatomy. Traditional ECG interpretation... Read more

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more